Perola E - Search Results

1

"Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase.

Bartolucci C, Perola E, Cellai L, Brufani M, Lamba D. Bartolucci C, et al. Among authors: perola e. Biochemistry. 1999 May 4;38(18):5714-9. doi: 10.1021/bi982723p. Biochemistry. 1999. PMID: 10231521

2

Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.

Perola E, Cellai L, Lamba D, Filocamo L, Brufani M. Perola E, et al. Biochim Biophys Acta. 1997 Nov 14;1343(1):41-50. doi: 10.1016/s0167-4838(97)00133-7. Biochim Biophys Acta. 1997. PMID: 9428657

3

Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs.

Bartolucci C, Perola E, Pilger C, Fels G, Lamba D. Bartolucci C, et al. Among authors: perola e. Proteins. 2001 Feb 1;42(2):182-91. doi: 10.1002/1097-0134(20010201)42:2<182::aid-prot50>3.0.co;2-1. Proteins. 2001. PMID: 11119642

4

Synthesis and activity studies of N-[omega-N'-(adamant-1'-yl)aminoalkyl]- 2-(4'-dimethylaminophenyl)acetamides: in the search of selective inhibitors for the different molecular forms of acetylcholinesterase.

Perola E, Cellai L, Brufani M. Perola E, et al. Bioorg Med Chem Lett. 1998 Mar 17;8(6):575-80. doi: 10.1016/s0960-894x(98)00076-6. Bioorg Med Chem Lett. 1998. PMID: 9871563

5

Inhibition of human leukocyte elastase by chemically and naturally oversulfated galactosaminoglycans.

Bartolucci C, Cellai L, Iannelli MA, Lamba D, Liverani L, Mascellani G, Perola E. Bartolucci C, et al. Among authors: perola e. Carbohydr Res. 1995 Oct 23;276(2):401-8. doi: 10.1016/0008-6215(95)00179-w. Carbohydr Res. 1995. PMID: 8542607

6

Fractions of chemically oversulphated galactosaminoglycan sulphates inhibit three enveloped viruses: human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus.

Di Caro A, Perola E, Bartolini B, Marzano M, Liverani L, Mascellani G, Benedetto A, Cellai L. Di Caro A, et al. Among authors: perola e. Antivir Chem Chemother. 1999 Jan;10(1):33-8. doi: 10.1177/095632029901000104. Antivir Chem Chemother. 1999. PMID: 10079877 Free article.

7

NMR structure of the chimeric hybrid duplex r(gcaguggc).r(gcca)d(CTGC) comprising the tRNA-DNA junction formed during initiation of HIV-1 reverse transcription.

Szyperski T, Götte M, Billeter M, Perola E, Cellai L, Heumann H, Wüthrich K. Szyperski T, et al. Among authors: perola e. J Biomol NMR. 1999 Apr;13(4):343-55. doi: 10.1023/a:1008350604637. J Biomol NMR. 1999. PMID: 10353196

8

HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA.

Götte M, Fackler S, Hermann T, Perola E, Cellai L, Gross HJ, Le Grice SF, Heumann H. Götte M, et al. Among authors: perola e. EMBO J. 1995 Feb 15;14(4):833-41. doi: 10.1002/j.1460-2075.1995.tb07061.x. EMBO J. 1995. PMID: 7533725 Free PMC article.

9

Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.

Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO. Govinda Rao B, et al. Among authors: perola e. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2250-3. doi: 10.1016/j.bmcl.2007.01.064. Epub 2007 Jan 26. Bioorg Med Chem Lett. 2007. PMID: 17289381

10

A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.

Perola E, Walters WP, Charifson PS. Perola E, et al. Proteins. 2004 Aug 1;56(2):235-49. doi: 10.1002/prot.20088. Proteins. 2004. PMID: 15211508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page